γ-Secretase Inhibitor Alleviates Acute Airway Inflammation of Allergic Asthma in Mice by Downregulating Th17 Cell Differentiation

T helper 17 (Th17) cells play an important role in the pathogenesis of allergic asthma. Th17 cell differentiation requires Notch signaling. γ-Secretase inhibitor (GSI) blocks Notch signaling; thus, it may be considered as a potential treatment for allergic asthma. The aim of this study was to evalua...

Full description

Saved in:
Bibliographic Details
Main Authors: Weixi Zhang (Author), Xueya Zhang (Author), Anqun Sheng (Author), Cuiye Weng (Author), Tingting Zhu (Author), Wei Zhao (Author), Changchong Li (Author)
Format: Book
Published: Hindawi Limited, 2015-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_5e0e7efc3f744f09a86f8e7a692c6bbf
042 |a dc 
100 1 0 |a Weixi Zhang  |e author 
700 1 0 |a Xueya Zhang  |e author 
700 1 0 |a Anqun Sheng  |e author 
700 1 0 |a Cuiye Weng  |e author 
700 1 0 |a Tingting Zhu  |e author 
700 1 0 |a Wei Zhao  |e author 
700 1 0 |a Changchong Li  |e author 
245 0 0 |a γ-Secretase Inhibitor Alleviates Acute Airway Inflammation of Allergic Asthma in Mice by Downregulating Th17 Cell Differentiation 
260 |b Hindawi Limited,   |c 2015-01-01T00:00:00Z. 
500 |a 0962-9351 
500 |a 1466-1861 
500 |a 10.1155/2015/258168 
520 |a T helper 17 (Th17) cells play an important role in the pathogenesis of allergic asthma. Th17 cell differentiation requires Notch signaling. γ-Secretase inhibitor (GSI) blocks Notch signaling; thus, it may be considered as a potential treatment for allergic asthma. The aim of this study was to evaluate the effect of GSI on Th17 cell differentiation in a mouse model of allergic asthma. OVA was used to induce mouse asthma model in the presence and absence of GSI. GSI ameliorated the development of OVA-induced asthma, including suppressing airway inflammation responses and reducing the severity of clinical signs. GSI also significantly suppressed Th17-cell responses in spleen and reduced IL-17 levels in serum. These findings suggest that GSI directly regulates Th17 responses through a Notch signaling-dependent pathway in mouse model of allergic asthma, supporting the notion that GSI is a potential therapeutic agent for the treatment of allergic asthma. 
546 |a EN 
690 |a Pathology 
690 |a RB1-214 
655 7 |a article  |2 local 
786 0 |n Mediators of Inflammation, Vol 2015 (2015) 
787 0 |n http://dx.doi.org/10.1155/2015/258168 
787 0 |n https://doaj.org/toc/0962-9351 
787 0 |n https://doaj.org/toc/1466-1861 
856 4 1 |u https://doaj.org/article/5e0e7efc3f744f09a86f8e7a692c6bbf  |z Connect to this object online.